BioNTech SE - Ordinary Shares, no par value per share (EUR1.00 nominal amount) (including Ordinary Shares represented by American Depositary Shares) (BNTX)

Q: What does CUSIP 09075V102 represent in this 13F holders report?

CUSIP 09075V102 is the security identifier for BNTX - BioNTech SE - Ordinary Shares, no par value per share (EUR1.00 nominal amount) (including Ordinary Shares represented by American Depositary Shares) used to aggregate holder disclosures.

Q: How many institutions held BNTX - BioNTech SE - Ordinary Shares, no par value per share (EUR1.00 nominal amount) (including Ordinary Shares represented by American Depositary Shares) in Q1 2023?

272 institutional investors reported BNTX - BioNTech SE - Ordinary Shares, no par value per share (EUR1.00 nominal amount) (including Ordinary Shares represented by American Depositary Shares) for Q1 2023. Use the holders table for investor-level position and value details.

CUSIP: 09075V102

Q1 2023 13F Holders as of 31 Mar 2023

Type / Class: Equity / Ordinary Shares, no par value per share (EUR1.00 nominal amount) (including Ordinary Shares represented by American Depositary Shares)
Shares outstanding: 239,647,920
Total 13F shares: 39,079,137
Share change: -573,454
Total reported value: $4,865,003,807
Put/Call ratio: 194%
Price per share: $124.57
Number of holders: 272
Value change: -$130,605,071
Number of buys: 117
Number of sells: 148

Quarterly Holders Quick Answers

What is CUSIP 09075V102?
CUSIP 09075V102 identifies BNTX - BioNTech SE - Ordinary Shares, no par value per share (EUR1.00 nominal amount) (including Ordinary Shares represented by American Depositary Shares) in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q2 2023
Previous quarter: Q4 2022

Recent filing periods for CUSIP 09075V102:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of BNTX - BioNTech SE - Ordinary Shares, no par value per share (EUR1.00 nominal amount) (including Ordinary Shares represented by American Depositary Shares) (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
BAILLIE GIFFORD & CO	13F	Company	3.2%	7,718,123	$1,159,416,437	—	31 Dec 2022	13F
Temasek Holdings (Private) Ltd	13F	Company	1.8%	4,378,022	$657,666,465	—	31 Dec 2022	13F
PRIMECAP MANAGEMENT CO/CA/	13F	Company	1.7%	4,173,166	$626,892,997	—	31 Dec 2022	13F
Se Flossbach von Storch	13F	Individual	1.4%	3,282,723	$493,130,649	—	31 Dec 2022	13F
Artisan Partners Limited Partnership	13F	Company	1%	2,406,700	$361,534,474	—	31 Dec 2022	13F
Capital World Investors	13F	Company	0.86%	2,068,248	$310,710,410	—	31 Dec 2022	13F
BlackRock Finance, Inc.	13F	Company	0.86%	2,058,523	$309,231,325	—	31 Dec 2022	13F
PRICE T ROWE ASSOCIATES INC /MD/	13F	Company	0.33%	784,278	$117,814,000	—	31 Dec 2022	13F
COATUE MANAGEMENT LLC	13F	Company	0.26%	618,231	$92,870,661	—	31 Dec 2022	13F
DEUTSCHE BANK AG\	13F	Company	0.25%	608,592	$91,422,691	—	31 Dec 2022	13F
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC	13F	Company	0.2%	480,301	$72,150,816	—	31 Dec 2022	13F
GILDER GAGNON HOWE & CO LLC	13F	Company	0.19%	458,420	$68,863,906	—	31 Dec 2022	13F
MORGAN STANLEY	13F	Company	0.19%	448,871	$67,429,401	—	31 Dec 2022	13F
SEI INVESTMENTS CO	13F	Company	0.16%	389,019	$58,438,434	—	31 Dec 2022	13F
MARSHALL WACE, LLP	13F	Company	0.16%	382,397	$57,494,109	—	31 Dec 2022	13F
FIRST TRUST ADVISORS LP	13F	Company	0.15%	352,262	$52,921,947	—	31 Dec 2022	13F
RENAISSANCE TECHNOLOGIES LLC	13F	Company	0.14%	331,484	$49,796,000	—	31 Dec 2022	13F
ACADIAN ASSET MANAGEMENT LLC	13F	Company	0.13%	312,164	$46,914,000	—	31 Dec 2022	13F
Nuveen Asset Management, LLC	13F	Company	0.13%	309,282	$46,461,000	—	31 Dec 2022	13F
ABEILLE ASSET MANAGEMENT SA	13F	Company	0%	4,726	$46,022,684	—	31 Dec 2022	13F
Point72 Asset Management, L.P.	13F	Company	0.13%	302,600	$45,456,572	—	31 Dec 2022	13F
Boston Common Asset Management, LLC	13F	Company	0.11%	269,803	$40,530,000	—	31 Dec 2022	13F
Quinn Opportunity Partners LLC	13F	Company	0.11%	262,071	$39,368,306	—	31 Dec 2022	13F
Deutsche Girozentrale DekaBank	13F	Individual	0.11%	252,780	$38,860,000	—	31 Dec 2022	13F
Mitsubishi UFJ Trust & Banking Corp	13F	Company	0.1%	247,230	$37,138,891	—	31 Dec 2022	13F
Baader Bank Aktiengesellschaft	13F	Company	0.1%	238,800	$35,881,130	—	31 Dec 2022	13F
COMGEST GLOBAL INVESTORS S.A.S.	13F	Company	0.09%	222,852	$33,476,827	—	31 Dec 2022	13F
Bellevue Group AG	13F	Company	0.09%	221,080	$33,210,638	—	31 Dec 2022	13F
Avidity Partners Management LP	13F	Company	0.09%	215,400	$32,357,388	—	31 Dec 2022	13F
FMR LLC	13F	Company	0.08%	182,552	$27,422,948	—	31 Dec 2022	13F
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP	13F	Company	0.07%	171,849	$25,815,000	—	31 Dec 2022	13F
GOLDMAN SACHS GROUP INC	13F	Company	0.07%	156,102	$23,449,643	—	31 Dec 2022	13F
S.c.a. Candriam	13F	Individual	0.06%	152,383	$22,889,902	—	31 Dec 2022	13F
VAN ECK ASSOCIATES CORP	13F	Company	0.06%	149,676	$22,484,000	—	31 Dec 2022	13F
Gates Foundation	13F	Company	0.06%	148,674	$22,333,808	—	31 Dec 2022	13F
FARALLON CAPITAL MANAGEMENT LLC	13F	Company	0.06%	140,000	$21,030,800	—	31 Dec 2022	13F
CITADEL ADVISORS LLC	13F	Company	0.06%	132,291	$19,872,754	—	31 Dec 2022	13F
UBS Group AG	13F	Company	0.05%	126,692	$19,031,672	—	31 Dec 2022	13F
MILLENNIUM MANAGEMENT LLC	13F	Company	0.05%	122,023	$18,330,000	—	31 Dec 2022	13F
STATE STREET CORP	13F	Company	0.05%	119,853	$18,004,318	—	31 Dec 2022	13F
BALYASNY ASSET MANAGEMENT L.P.	13F	Company	0.05%	113,528	$17,054,176	—	31 Dec 2022	13F
PICTET ASSET MANAGEMENT SA	13F	Company	0.05%	109,026	$16,378,000	—	31 Dec 2022	13F
Rhenman & Partners Asset Management AB	13F	Company	0.05%	109,000	$16,373,980	—	31 Dec 2022	13F
Tekla Capital Management LLC	13F	Company	0.04%	103,858	$15,601,549	—	31 Dec 2022	13F
BANK OF AMERICA CORP /DE/	13F	Company	0.04%	102,209	$15,353,836	—	31 Dec 2022	13F
Legal & General Group Plc	13F	Company	0.04%	94,501	$14,444,157	—	31 Dec 2022	13F
SUSQUEHANNA INTERNATIONAL GROUP, LLP	13F	Company	0.04%	95,414	$14,333,091	—	31 Dec 2022	13F
Redwood Investments, LLC	13F	Company	0.04%	87,540	$13,150,259	—	31 Dec 2022	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	0.03%	83,332	$12,518,000	—	31 Dec 2022	13F
De L'Echiquier la Financiere	13F	Individual	0.03%	81,739	$12,279,000	—	31 Dec 2022	13F

Institutional Holders of BioNTech SE - Ordinary Shares, no par value per share (EUR1.00 nominal amount) (including Ordinary Shares represented by American Depositary Shares) (BNTX) as of Q1 2023

As of 31 Mar 2023, BioNTech SE - Ordinary Shares, no par value per share (EUR1.00 nominal amount) (including Ordinary Shares represented by American Depositary Shares) (BNTX) was held by 272 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 39,079,137 shares. The largest 10 holders included BAILLIE GIFFORD & CO, PRIMECAP MANAGEMENT CO/CA/, Temasek Holdings (Private) Ltd, FLOSSBACH VON STORCH AG, Artisan Partners Limited Partnership, BlackRock Inc., Capital World Investors, MORGAN STANLEY, DEUTSCHE BANK AG\, and ALTRINSIC GLOBAL ADVISORS LLC. This page lists 274 institutional shareholders reporting positions in this security for the Q1 2023 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q1 2023 vs Q4 2022 Across Filers

Q4 2022 holders

312

Q1 2023 holders

272

Holder diff

-40

Investor	Q4 2022 Shares	Q1 2023 Shares	Share Diff	Share Chg %	Q4 2022 Value $	Q1 2023 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.